Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04342637 · ClinicalTrials.gov registry record

COVID-19 Endoscopy Survey

A clinical trial of COVID-19, sponsored by Al-Azhar University.

Completed
Registry status
163
Enrollment target
4
Study locations

NCT04342637 is a study of COVID-19 that has completed, run by Al-Azhar University. The registered enrollment target is 163 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04342637, a study of COVID-19, has completed, sponsored by Al-Azhar University.

COMPLETED
Registry status
163 participants
Enrollment target
4
Study locations

Study Summary

A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.

Conditions Studied

Interventions

  • OTHER Practice details

Study Locations (4)

Other

  • Al-Azhar Univerisity - Cairo
  • Ahvaz Imam hospital - Ahvāz

New York

  • Kings County Hospital Center, Brooklyn, NY, USA - Albertson

Sharqia Province

  • Faculty of Medicine, Zagazig University - Zagazig

Trial Details

FieldValue
Enrollment Target 163 participants
Start Date 2020-04-10
Est. Completion 2020-05-01

Sponsor

Al-Azhar University

2 total trials

What the Registry Record Tells You About NCT04342637

The ClinicalTrials.gov registry entry for NCT04342637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Al-Azhar University, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Practice details is the first listed.

NCT04342637 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Sharqia Province.

Frequently Asked Questions

What is clinical trial NCT04342637 about?

NCT04342637 is a clinical study titled "COVID-19 Endoscopy Survey". A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endosc...

What is the current status of trial NCT04342637?

This trial is currently completed. The enrollment target is 163 participants. The study started on 2020-04-10. Estimated completion is 2020-05-01.

What conditions does trial NCT04342637 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04342637?

The interventions under investigation include: Practice details (OTHER).

Who is sponsoring clinical trial NCT04342637?

This trial is sponsored by Al-Azhar University, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04342637 being conducted?

This trial has 4 study locations across New York, Sharqia Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.